2018 |
R43 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues |
Active |
1999 |
R43 |
CA083385 |
PAR-98-066 |
GOLDRICK, MARIANNA M |
AMBION, INC. |
DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA |
Complete |
2000 |
R43 |
CA088381 |
PAR-99-101 |
RENARD, ANDRE |
INTERGEN COMPANY |
PYRENE-CONTAINING PROBES FOR MUTATION DETECTION |
Complete |
2002 |
R43 |
CA097507 |
PAR-01-105 |
MC GARRITY, GERARD J. |
INTRONN, INC. |
PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER |
Complete |
2018 |
R43 |
CA236101 |
PAR-18-303 |
LEE, LY JAMES |
NANOMATERIAL INNOVATION, LTD |
Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis |
Complete |
1999 |
R43 |
CA083388 |
PAR-98-066 |
CRONIN, MAUREEN T. |
PROTOGENE LABORATORIES, INC. |
DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD |
Complete |
2017 |
R43 |
CA214386 |
PAR-13-327 |
PEYTAVI, REGIS |
BLUENOVO BIOSYSTEMS, INC. |
Detection of Methylation and Translocation Events by Novel Sequencing Technology |
Complete |
2000 |
R43 |
CA088396 |
PAR-99-101 |
MOEN, PHILLIP T |
ONE CELL SYSTEMS, INC |
DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS |
Complete |
2018 |
R43 |
CA236142 |
PAR-18-303 |
SCHOETTLE, LOUIS |
GEMNEO BIOSCIENCE, INC. |
Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes |
Complete |
1999 |
R43 |
CA083390 |
PAR-98-066 |
WIKTOR, PETER J. |
ENGINEERING ARTS |
PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS |
Complete |
2020 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations |
Active |
2000 |
R43 |
CA088696 |
PAR-99-101 |
CHO, RAYMOND JAIHYUN |
INGENUITY SYSTEMS, INC. |
FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS |
Complete |
2019 |
R43 |
CA236103 |
PAR-18-303 |
KHODAVERDIAN, VARANDT Y. |
NUPROBE USA, INC. |
Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing |
Complete |
1999 |
R43 |
CA083396 |
PAR-98-066 |
GITE, SADANAND |
AMBERGEN, INC |
NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION |
Complete |
2019 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations |
NCE |
1999 |
R43 |
CA083398 |
PAR-98-066 |
CHEE, MARK S. |
ILLUMINA, INC. |
PARALLEL ARRAY PROCESSOR |
Complete |
2020 |
R44 |
CA250672 |
PAR-18-303 |
WINTERS, IAN PAUL |
D2G ONCOLOGY, INC. |
Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform |
Active |
2000 |
R44 |
CA081954 |
PAR-98-066 |
LIFSHITZ, NADIA |
BIOPHOTONICS CORPORATION |
HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING |
Complete |
2002 |
R44 |
CA088396 |
PAR-01-105 |
MOEN, PHILLIP T |
ONE CELL SYSTEMS, INC |
DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS |
Complete |
2000 |
R44 |
CA082038 |
PAR-98-066 |
ANDERSON, N LEIGH |
LARGE SCALE BIOLOGY CORPORATION |
PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH |
Complete |
1999 |
R44 |
CA081954 |
PAR-98-066 |
LIFSHITZ, NADIA |
BIOPHOTONICS CORPORATION |
HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING |
Complete |
1999 |
R44 |
CA082038 |
PAR-98-066 |
ANDERSON, N LEIGH |
LARGE SCALE BIOLOGY CORPORATION |
PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH |
Complete |
2005 |
R44 |
CA101106 |
RFA-CA-05-006 |
RUSH, JOHN |
CELL SIGNALING TECHNOLOGY, INC. |
IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES |
Complete |
2005 |
R44 |
CA107988 |
PAR-01-105 |
BALGLEY, BRIAN M. |
CALIBRANT BIOSYSTEMS, INC. |
INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS |
Complete |
2008 |
R44 |
CA134258 |
RFA-CA-07-039 |
GUO, BAOCHUAN |
GLC BIOTECHNOLOGY, INC. |
MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY |
Complete |
2008 |
R44 |
CA134310 |
RFA-CA-07-041 |
LEE, BRIAN W |
IMMUNOCHEMISTRY TECHNOLOGIES, LLC |
NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO |
Complete |
2006 |
R44 |
CA118785 |
RFA-CA-06-006 |
BROWN, DAVID M |
AMBION DIAGNOSTICS, INC. |
MIRNA PROFILING IN FIXED CANCER SAMPLES |
Complete |
2008 |
R44 |
CA114126 |
RFA-CA-07-039 |
LIM, MARK |
AMBERGEN, INC |
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE |
Complete |
2006 |
R44 |
CA097569 |
RFA-CA-06-005 |
BRADY, ERIK D |
MICROCOSM, INC. |
ENHANCED CANCER MICROARRAY |
Complete |
2008 |
R44 |
CA120619 |
RFA-CA-07-041 |
LEE, PHILIP J |
CELLASIC CORPORATION |
MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS |
Complete |
2006 |
R44 |
CA121155 |
RFA-CA-06-005 |
LU, PETER S. |
ARBOR VITA CORPORATION |
A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES |
Complete |
2020 |
R44 |
CA247353 |
PAR-18-303 |
FRIEDA, KIRSTEN |
SPATIAL GENOMICS, INC. |
Spatial and single cell analysis of tumor microenvironment by seqFISH+ |
Active |
2008 |
R44 |
CA118785 |
RFA-CA-06-006 |
BROWN, DAVID M |
AMBION DIAGNOSTICS, INC. |
MIRNA PROFILING IN FIXED CANCER SAMPLES |
Complete |
2008 |
R44 |
CA128858 |
RFA-CA-07-008 |
DOLINGER, DAVID LEE |
IQUUM, INC. |
RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS |
Complete |
2021 |
R44 |
CA261523 |
PAR-18-303 |
HUNG, PAUL JU-SUNG |
COMBINATI, INC. |
Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring |
Active |
2016 |
R44 |
CA199194 |
PAR-13-327 |
KARSTEN, STANISLAV |
NEUROINDX INC. |
Automated Platform for Fixed Tissue Microdissection |
Complete |
2016 |
R44 |
CA187852 |
PAR-13-327 |
JOHNSON, DAVID SCOTT |
GIGAGEN, INC. |
Next-Generation Antibody Discovery and Development Technology |
Complete |
2020 |
R44 |
CA243990 |
PAR-18-303 |
GURARD-LEVIN, ZACHARY |
SAMDI TECH, INC. |
Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities |
Active |
2001 |
R44 |
CA081952 |
PAR-99-101 |
CHEE, MARK S. |
ILLUMINA, INC. |
RANDOM ARRAYS FOR GENE EXPRESSION PROFILING |
Complete |
2004 |
R44 |
CA081903 |
PAR-01-106 |
TS'O, PAUL O. P. |
CCC DIAGNOSTICS, LLC |
CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS |
Complete |
2001 |
R44 |
CA081965 |
PAR-99-101 |
BITTER, GRANT A. |
BITTECH, INC. |
DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS |
Complete |
2004 |
R44 |
CA105539 |
PAR-01-105 |
BATTRELL, CHARLES FRED |
MICRONICS, INC. |
MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER |
Complete |
2009 |
R44 |
CA140047 |
RFA-CA-08-011 |
CHEN, WEN-TIEN |
VITATEX, INC. |
CANCER PROGENIYOR CELL MARKERS |
Complete |
2001 |
R44 |
CA083396 |
PAR-99-101 |
GITE, SADANAND |
AMBERGEN, INC |
NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION |
Complete |
2004 |
R44 |
CA107988 |
PAR-01-105 |
BALGLEY, BRIAN M |
CALIBRANT BIOSYSTEMS, INC. |
INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS |
Complete |
2009 |
R44 |
CA115041 |
RFA-CA-08-013 |
ZOU, NIANXIANG |
BIO-QUICK CORPORATION |
DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE |
Complete |
2001 |
R44 |
CA083598 |
PAR-99-101 |
RAO, CHANDRA |
IMMUNICON CORPORATION |
ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE |
Complete |
2004 |
R44 |
CA099126 |
PAR-01-105 |
ZEBALA, JOHN A |
SYNTRIX BIOSYSTEMS, INC. |
ARTIFICIAL ANTIBODY MIMETICS |
Complete |
2003 |
R44 |
CA084804 |
PAR-01-104 |
GOLOVLEV, VAL V |
SCI-TEC, INC. |
MAGNETICALLY READABLE MICROARRAY |
Complete |
2009 |
R44 |
CA130026 |
RFA-CA-07-010 |
LEVENSON, RICHARD M. |
CAMBRIDGE RESEARCH AND INSTRUMENTATION |
CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING |
Complete |